These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34807506)

  • 21. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
    Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
    Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stemness of CD10-positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma.
    Wang Y; Li Q; Xu L; Chen J; Pu Y; Wang L; Sun H; Guo Y; Guo C
    Oral Dis; 2021 Sep; 27(6):1403-1411. PubMed ID: 33037760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
    Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
    Xu T; Zhang W; Chai L; Liu C; Zhang S; Xu T
    Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
    Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
    Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway.
    Shriwas O; Arya R; Mohanty S; Mohapatra P; Kumar S; Rath R; Kaushik SR; Pahwa F; Murmu KC; Majumdar SKD; Muduly DK; Dixit A; Prasad P; Nanda RK; Dash R
    Br J Cancer; 2021 Jun; 124(12):2004-2016. PubMed ID: 33762722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
    Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
    Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma.
    Wu T; Xiao Z; Li Y; Jiao Z; Liang X; Zhang Y; Liu H; Yang A
    Asian J Surg; 2022 Dec; 45(12):2651-2658. PubMed ID: 35305877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
    Zeng H; Zhao X; Tang C
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):223-233. PubMed ID: 33907880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
    Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
    Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition.
    Kashyap T; Nath N; Mishra P; Jha A; Nagini S; Mishra R
    Head Neck; 2020 Nov; 42(11):3282-3294. PubMed ID: 32710593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.
    Li S; Wu Y; Ding Y; Yu M; Ai Z
    J Cell Physiol; 2018 Dec; 233(12):9416-9425. PubMed ID: 30054909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma.
    Wang C; Kadigamuwa C; Wu S; Gao Y; Chen W; Gu Y; Wang S; Li X
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
    Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.